Nevertheless, some countries in Asia still recommend the use of AFP along with USG for the screening of HCC in the guideline published by Asian Pacific Association for the Study of the Liver in the year 2010 [15], and the guideline published by China (2011) [16] and Japan (2013) [17]. This evidence concerns the gene AFP and hepatocellular carcinoma.